An illustration of the modelling of cost and efficacy data from a clinical trial

Statistics in Medicine

Volumn 22, Issue 6, 2003, Pages 1009-1024

  Hahn, Seokyung ^a   Whitehead, Anne ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Bayesian approach; Cost effectiveness; Cost effectiveness acceptability curve; Frequentist approach; Net benefit; Statistical modelling

Indexed keywords

BAYES THEOREM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; HEALTH CARE ORGANIZATION; HERNIOPLASTY; HUMAN; INGUINAL HERNIA; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL MODEL; SURGICAL TECHNIQUE;

BAYES THEOREM; CONTROLLED CLINICAL TRIALS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; HERNIA, INGUINAL; HUMANS; LAPAROSCOPY; MODELS, ECONOMIC;

EID: 0037473230     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1459     Document Type: Review

References (18)

1. O'Brien BJ, Drummond MF, Lebelle RJ, Willan A. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Medical Care 1994; 32:150-163.
2. Wakker P, Klaassen MP. Confidence intervals for cost-effectiveness ratios. Health Economics 1995; 4:373-381.
3. Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomised trial. Statistics in Medicine 1996; 15:1447-1458.
4. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Econometrics and Health Economics 1997; 6:327-340.
5. Stinnett AA, Mullahy J. Net Health Benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making 1998; 18(suppl):S68-S80.
6. Tambour M, Zethraeus N, Johannesson M. A note on confidence intervals in cost-effectiveness analysis. International Journal of Technology Assessment in Health care 1998; 14:467-471.
7. van Hout BA, Al MJ, Gordon GS, Rutten FFH. Cost, effects and C/E-ratios alongside a clinical trial. Health Economics 1994; 3:309-319.
8. Löthgren M, Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Economics 2000; 9:623-630.
9. Briggs AH. A Bayesian approach to stochastic cost-effectiveness analysis. Health Economics 1999; 8:257-261.
10. Claxton K, Lacey LF, Walker SG. Selecting treatment: a decision theoretic approach. Journal of the Royal Statistical Society, Series A 2000; 163:211-225.
11. O'Hagan A, Stevens JW, Montmartin J. Bayesian cost-effectiveness analysis from clinical trial data. Statistics in Medicine 2001; 20:733-753.
12. O'Hagan A, Stevens JW. A framework for cost-effectiveness analysis from clinical trial data. Health Economics 2001; 10:303-315.
13. National Institute for Clinical Excellence. Guidance on the use of laparoscopic surgery for inguinal hernia. Technology Appraisal Guidance No. 18, NICE, London, 2001 (available electronically at http://www.nice.org.uk/pdf/Laphernias_full_guidance.pdf).
14. Vale L, McCormack K, Scott N, Grant A. Systematic review of the effectiveness and cost-effectiveness of laparoscopic versus open repair of inguinal hernia. Health Technology Assessment Report, 2000 (available electronically at http://www.nice.org.uk/pdf/Laphernias_HTAreppartl.pdf).
15. Wellwood J, Sculpher MJ, Stoker D, Nicholls GJ, Gedds C, Whitehead A, Singh R, Spiegelhalter D. Randomised controlled trial of laparoscopic versus open mesh repair for inguinal hernia: outcome and cost. British Medical Journal 1998; 317:103-110.
16. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. Journal of Health Economics 1999; 18:341-364.
17. Spiegelhalter DJ, Thomas A, Best NG, Gilks WR. BUGS: Bayesian Inference Using Gibbs Sampling. Version 0.50. MRC Biostatistics Unit: Cambridge, 1995.
18. O'Hagan A, Stevens JW. Assessing and comparing cost: how robust are the bootstrap and methods based on asymptotic normality? Health Economics 2003; 12:33-49.